Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DELTA Trial: De-escalated Letrozole in HR+ Early Breast Cancer
NCT07866430Phase 2Not yet recruiting
- Sponsor
- Montefiore Medical Center
- Start
- Sep 2026
- Primary completion
- Oct 2032
- Countries
- 1
01
Overview
A Phase 2 trial of letrozole in breast cancer, sponsored by Montefiore Medical Center. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07866430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07866430.